Invention Grant
![Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds](/docs/US/2014-09-02/US08822456B2/abs.jpg.600x600.jpg)
- Patent Title: Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
- Patent Title (中): 六氢吡喃并[3,4-d] [1,3]噻嗪-2-胺化合物
-
Application No.: US14101462Application Date: 2013-12-10
-
Publication No.: US08822456B2Publication Date: 2014-09-02
- Inventor: Michael Aaron Brodney , Elizabeth Mary Beck , Christopher Ryan Butler , Jennifer Elizabeth Davoren , Brian Thomas O'Neill
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent John A. Wichtowski
- Main IPC: C07D513/04
- IPC: C07D513/04 ; A61K31/542
![Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds](/abs-image/US/2014/09/02/US08822456B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides compounds of Formula I, and the tautomers thereof, and the pharmaceutically acceptable salts of the compounds and tautomers, wherein the compounds have the structure wherein the variables R1, R2, R3, R4 and x are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Public/Granted literature
- US20140163015A1 HEXAHYDROPYRANO[3,4-d][1,3]THIAZIN-2-AMINE COMPOUNDS Public/Granted day:2014-06-12
Information query
